BioLineRx Net Income Per Share from 2010 to 2026
| BLRX Stock | USD 2.71 0.08 3.04% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -0.01 | Current Value -0.01 | Quarterly Volatility 0.3842749 |
Macro event markers
Analyzing BioLineRx's Net Income Per Share over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income Per Share has evolved provides context for assessing BioLineRx's current valuation and future prospects.
Latest BioLineRx's Net Income Per Share Growth Pattern
Below is the plot of the Net Income Per Share of BioLineRx over the last few years. It is BioLineRx's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioLineRx's overall financial position and show how it may be relating to other accounts over time.
| Net Income Per Share | 10 Years Trend |
|
Net Income Per Share |
| Timeline |
BioLineRx Net Income Per Share Regression Statistics
| Arithmetic Mean | -0.28 | |
| Geometric Mean | 0.12 | |
| Coefficient Of Variation | -138.86 | |
| Mean Deviation | 0.27 | |
| Median | -0.18 | |
| Standard Deviation | 0.38 | |
| Sample Variance | 0.15 | |
| Range | 1.3749 | |
| R-Value | 0.61 | |
| Mean Square Error | 0.1 | |
| R-Squared | 0.38 | |
| Significance | 0.01 | |
| Slope | 0.05 | |
| Total Sum of Squares | 2.36 |
BioLineRx Net Income Per Share History
Methodology, Assumptions & Data Sources
The time-series view of Net Income Per Share for BioLineRx offers a foundation for growth-rate and stability analysis. Volatility in this series can indicate sensitivity to macro or sector-level shifts.
Macroaxis compiles BioLineRx metrics from periodic company reporting and market reference feeds and applies consistent transformation rules before display. Where analyst coverage exists, consensus estimates are factored in. Not all fields update in real time. This section presents reference data and historical patterns only and does not constitute an investment recommendation or advice.